Subhash Banerjee, MD
Cardiovascular Disease · Dallas, TXNPI 1407892458
Payments from drug & device makers
Across 271 payments — averaging $3685.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GE HealthCare$340K
- Boston Scientific$220K
- Esperion Therapeutics, Inc.$167K
- Teleflex LLC$67K
- Abbott$60K
- AstraZeneca$37K
- plus $108K from 29 others
Across 1 payment — averaging $2000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GE HealthCare | 18 | $339,970 |
| Boston Scientific | 20 | $220,303 |
| Esperion Therapeutics, Inc. | 6 | $166,664 |
| Teleflex LLC | 14 | $66,806 |
| Abbott | 10 | $60,344 |
| AstraZeneca | 11 | $36,933 |
| Bayer | 7 | $20,840 |
| Kaneka Medical America LLC | 5 | $17,095 |
| Cardiovascular Systems Inc. | 9 | $16,572 |
| Biotronik Inc. | 9 | $12,637 |
| Philips North America LLC | 1 | $10,000 |
| Novartis | 3 | $9,645 |
| Boehringer Ingelheim | 1 | $5,119 |
| Medtronic(2 entities) | 51 | $3,469 |
| Cardinal Health 200 LLC | 7 | $2,609 |
| Cordis US CORP. | 13 | $2,201 |
| Terumo Medical Corporation | 8 | $1,889 |
| Edwards Lifesciences | 36 | $1,878 |
| Amgen | 13 | $1,330 |
| Abiomed | 5 | $678 |
| Shockwave Medical, Inc | 3 | $306 |
| Spectrawave, Inc | 3 | $297 |
| Limflow Inc. | 1 | $297 |
| W. L. Gore & Associates, Inc. | 2 | $237 |
| Penumbra, Inc. | 1 | $150 |
| Siemens Medical Solutions USA, Inc. | 1 | $100 |
| Regeneron | 1 | $97 |
| Heartflow, Inc. | 2 | $56 |
| Cardiva Medical, Inc. | 1 | $56 |
| Novo Nordisk | 3 | $49 |
| Tactile Systems Technology Inc | 1 | $36 |
| Convatec Inc. | 1 | $28 |
| Cvrx, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $18 |
How this compares
$998,752 in reported general payments places this provider in the 95th percentile of 1,515 cardiovascular disease providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Dallas
- Ramin Farzaneh-FarDallas$17.1M
- Jeffrey GladdenDallas$15.8M
- Ann NavarDallas$14.5M
- Justin GrodinDallas$6.2M
- Ambarish PandeyDallas$2.9M
- Paul GrayburnDallas$1.8M
- Parag KaleDallas$1.5M
- Eric PetersonDallas$1.4M
- Parag JoshiDallas$1.4M
- Darren McGuireDallas$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.